Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)

14.37 -0.21 (-1.44%)

Streaming Delayed Price Updated: 3:37 PM EST, Feb 26, 2026 Add to My Watchlist

Price and Volume

Volume	1,018,275
Open	14.58
Bid (Size)	14.37 (700)
Ask (Size)	14.38 (400)
Prev. Close	14.58
Today's Range	14.30 - 14.66
52wk Range	6.685 - 15.42
Shares Outstanding	1,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Earnings To Watch: Amneal (AMRX) Reports Q4 Results Tomorrow

February 25, 2026

Pharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) will be reporting results this Friday morning. Here’s what you need to know.

Via StockStory

Supreme Court Strikes Down IEEPA Tariffs, Mandating Billions in Immediate Rebates

February 24, 2026

In a seismic shift for global trade and constitutional law, the Supreme Court of the United States ruled on February 20, 2026, that the executive branch lacks the authority to unilaterally impose...

Via MarketMinute

Performance

YTD	+13.5%	+13.5%
1 Month	+5.9%	+5.9%
3 Month	+14.8%	+14.8%
6 Month	+53.5%	+53.5%
1 Year	+69.1%	+69.1%

More News

3 Russell 2000 Stocks We Find Risky

February 12, 2026

Via StockStory

3 Small-Cap Stocks That Fall Short

February 04, 2026

Via StockStory

3 Cash-Producing Stocks That Concern Us

February 01, 2026

Via StockStory

3 Healthcare Stocks We Steer Clear Of

January 29, 2026

Via StockStory

Amneal Pharmaceuticals Added to S&P SmallCap 600® Index

January 28, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026

January 27, 2026

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

2 Reasons to Sell AMRX and 1 Stock to Buy Instead

January 25, 2026

Via StockStory

Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®

December 22, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

1 Small-Cap Stock to Target This Week and 2 That Underwhelm

December 17, 2025

Via StockStory

Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals

December 09, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson’s Disease

December 05, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

3 Healthcare Stocks We’re Skeptical Of

December 02, 2025

Via StockStory

Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol

December 02, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal to Participate in Upcoming Investor Conferences

December 02, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%

December 01, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

Is Amneal Stock a Buy After Investment Firm Westshore Wealth Bought Over 1 Million Shares? ↗

November 28, 2025

Via The Motley Fool

Natera, Amneal, Chemed, The Pennant Group, and HCA Healthcare Shares Are Soaring, What You Need To Know

November 21, 2025

Via StockStory

Amneal EVP Sells $1.6 Million in Shares as Stock Trades Near Multi-Year Highs ↗

November 21, 2025

Via The Motley Fool

Unpacking Q3 Earnings: Amneal (NASDAQ:AMRX) In The Context Of Other Generic Pharmaceuticals Stocks

November 19, 2025

Via StockStory

3 Russell 2000 Stocks with Warning Signs

November 13, 2025

Via StockStory

Amneal Receives U.S. FDA Approval for Iohexol Injection

November 13, 2025

From Amneal Pharmaceuticals LLC

Via GlobeNewswire

3 Stocks Under $50 We Steer Clear Of

November 11, 2025

Via StockStory

Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know

November 11, 2025

Via StockStory

Frequently Asked Questions

Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?

Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.

What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?

Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market

What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 14.37

When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?

The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 02/26/26 03:37 PM ET

What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?

The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 14.37K

How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?

Amneal Pharmaceuticals, Inc. - Class A Common Stock has 14K shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.